Advertisement
Lotte Biologics signs CDMO deal with U.S. firm for antibody drug substance
World

Lotte Biologics signs CDMO deal with U.S. firm for antibody drug substance

April 1, 2026
Yonhap News Agency
Scroll

SEOUL, April 1 (Yonhap) -- Lotte Biologics Co., the biotech arm of Lotte Group, ...

Lotte Biologics signs CDMO deal with U.S. firm for antibody drug substance
Read Full Article
Yonhap News Agency
Yonhap News Agency

Coverage and analysis from South Korea. All insights are generated by our AI narrative analysis engine.

South Korea
Bias: lean right
Advertisement
You might also like

Explore More